Nova Leap Health (TSE:NLH) has released an update.
Nova Leap Health Corp. reported modest revenue growth in the first quarter of 2024, with a slight 0.5% increase from the same quarter the previous year, despite a 1.9% dip from the preceding quarter. However, the company experienced a significant decline in its adjusted EBITDA, dropping by 36.7% from the last quarter of 2023, but still reflecting a substantial year-over-year increase of 321% from Q1 2023.
For further insights into TSE:NLH stock, check out TipRanks’ Stock Analysis page.
